Our audiology services
Screening for Neurocognitive Disorders

Neurocognitive Disorders: Detect Early to Intervene Effectively!

Neurocognitive disorders, such as Alzheimer's disease and other forms of dementia, affect approximately 7.1% of individuals aged 65 and older, and this prevalence increases with age.1 These disorders can significantly impact the quality of life, autonomy, and safety of older adults.

Numerous studies have also demonstrated a strong link between untreated hearing loss and cognitive decline. Moderate hearing impairment can increase the risk of developing neurocognitive disorders by up to three times. 2 In individuals with hearing loss, the areas of the brain responsible for memory may atrophy due to insufficient stimulation. 3 Additionally, uncorrected hearing loss often leads to social isolation, which represents another risk factor. 4 Hearing loss is the potentially modifiable risk factor that has the greatest impact on the risk of cognitive decline.3

Early screening for these conditions allows for better management aimed at optimizing possible interventions.

In this context, we are offering a new screening service for neurocognitive disorders specifically designed for individuals aged 65 and over.

   Make an appointment    

Our Approach:

  • In-person appointment lasting 15 to 30 minutes;
  • Administration of standardized cognitive tests and validated questionnaires;
  • Discussion of symptoms, medical history, and risk factors;
  • Opportunity to explore the link between cognition and hearing;
  • A medical referral is suggested when needed for specialized evaluation or follow-up.

This service aims to support older adults and their families in understanding age-related cognitive changes while facilitating quick access to appropriate resources.

Did you know that wearing a properly fitted hearing aid with recent data greatly helps to prevent and reduce the risks of cognitive decline? 5 Consequently, it is crucial not to miss your audiology follow-up!

1. Public Health Agency of Canada. Dementia in Canada, including Alzheimer's disease. Accessed June 26, 2025.
2. World Health Organization and the Lancet Commission (2020 and 2024). Accessed June 26, 2025.
3. Source: Dementia prevention, intervention and care: 2020 report of the Lancet Commissions. Accessed June 26, 2025.
4. Source: Dementia prevention, intervention and care: 2017 report of the Lancet Commissions. Accessed June 30, 2025.
5. Source: Dementia prevention, intervention and care: 2024 report of the Lancet Commissions. Accessed June 30, 2025.